Jump to content

Drug-induced thrombocytopenic purpura

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 08:09, 1 January 2021 (Task 18 (cosmetic): eval 1 template: del empty params (5×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Drug-induced thrombocytopenic purpura
SpecialtyDermatology

Drug-induced thrombocytopenic purpura is a skin condition result from a low platelet count due to drug-induced anti-platelet antibodies caused by drugs such as heparin, sulfonamines, digoxin, quinine, and quinidine.[1]: 821 

See also

References

  1. ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.